FLT3LG seems to exert its anti-tumor activity in conjunction with macrophages and CD4 + T-cells in glioma [72], supporting the observation of a specific immune-modulatory effect of CIR [9]. The gene discussed is FLT3LG; the disease is central nervous system cancer.